Skinvisible, Inc.

SKVI Biotech & pharma

Develops topical skin products for dermatology and skincare.

Jun 2026Revenue $20.0K/yrExpenses $479K/yr
No trend
Figures by year

When will Skinvisible be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $20.0K and expenses $479K.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$20.0K$516K−$496K
Dec 2024$20.0K$610K−$590K
Dec 2023$20.0K$510K−$490K
Dec 2022$279K$518K−$238K
Dec 2021$663K$475K$188K
Dec 2020$153K$406K−$254K
Dec 2019$42.1K$582K−$540K
Dec 2018$69.3K$667K−$598K
Dec 2017$629K$993K−$364K
Dec 2016$109K$951K−$842K